These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20423242)

  • 1. Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets.
    Eugster-Hausmann M; Waitzinger J; Lehnick D
    Climacteric; 2010 Jun; 13(3):219-27. PubMed ID: 20423242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL; Gattermeir DJ; Petersen CA; Day WW; Schumacher RJ
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
    Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
    Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace level quantification of deuterated 17beta-estradiol and estrone in ovariectomized mouse plasma and brain using liquid chromatography/tandem mass spectrometry following dansylation reaction.
    Xia YQ; Chang SW; Patel S; Bakhtiar R; Karanam B; Evans DC
    Rapid Commun Mass Spectrom; 2004; 18(14):1621-8. PubMed ID: 15282788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H; Koytchev R; Mayer O; Börner A; Mellinger U; Breitbarth H
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM; Blauer KL; Hansen M; Stanczyk F; Lobo R; Bates GW
    Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, multiple-dose parallel study to compare the pharmacokinetic parameters of synthetic conjugated estrogens, A, administered as oral tablet or vaginal cream.
    Bhamra RK; Margolis MB; Liu JH; Hendy CH; Jenkins RG; DiLiberti CE
    Menopause; 2011 Apr; 18(4):393-9. PubMed ID: 21107298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
    Geisler J; Ekse D; Helle H; Duong NK; Lønning PE
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):90-5. PubMed ID: 18242079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
    Karara AH; Harrison LI; Melikian AP; Poola N; Morrison D; Bourg D; Bourg L; Zurth C
    J Clin Pharmacol; 2014 May; 54(5):520-7. PubMed ID: 24474034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
    Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
    Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS coupled with immunoaffinity extraction for determination of estrone, 17beta-estradiol and estrone 3-sulfate in human plasma.
    Hosogi J; Tanaka H; Fujita K; Kuwabara T; Ikegawa S; Kobayashi N; Mano N; Goto J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):222-7. PubMed ID: 19700374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA; Zegarac EA; Eldon MA; Sedman AJ; Forgue ST
    Biopharm Drug Dispos; 1996 Aug; 17(6):459-70. PubMed ID: 8866037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letrozole suppresses plasma estradiol and estrone sulphate more completely than anastrozole in postmenopausal women with breast cancer.
    Dixon JM; Renshaw L; Young O; Murray J; Macaskill EJ; McHugh M; Folkerd E; Cameron DA; A'Hern RP; Dowsett M
    J Clin Oncol; 2008 Apr; 26(10):1671-6. PubMed ID: 18375896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.